{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:47:12Z","timestamp":1788922032401,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ajoc.2024.102204","type":"journal-article","created":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T05:39:59Z","timestamp":1729402799000},"page":"102204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A telemedicine-enabled intravenous thrombolytic treatment pathway for patients with hyperacute non-arteritic central retinal artery occlusion"],"prefix":"10.1016","volume":"36","author":[{"given":"Aubrey L.","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Sax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Tariq","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronak","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Dokey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tova","family":"Mannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9309-391X","authenticated-orcid":false,"given":"Robin A.","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajoc.2024.102204_bib1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajo.2005.03.038","article-title":"Central retinal artery occlusion: visual outcome","volume":"140","author":"Hayreh","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"23","key":"10.1016\/j.ajoc.2024.102204_bib2","article-title":"Central retinal artery occlusion: visual outcomes from a large northern California cohort","volume":"S2468\u20136530","author":"Shah","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"10.1016\/j.ajoc.2024.102204_bib3","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102204_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/WNO.0000000000001027","article-title":"Thrombolysis for central retinal artery occlusion in 2020: time is vision","volume":"40","author":"Dumitrascu","year":"2020","journal-title":"J Neuro Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2024.102204_bib5","first-page":"e282","article-title":"Thrombosis and vascular biology; council on hypertension; and council on peripheral vascular disease. Management of central retinal artery occlusion: a scientific statement from the American heart association","volume":"52","author":"Mac","year":"2021","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.ajoc.2024.102204_bib6","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jamaneurol.2015.1578","article-title":"Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis","volume":"72","author":"Schrag","year":"2015","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.ajoc.2024.102204_bib7","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1161\/STROKEAHA.119.028743","article-title":"Intravenous fibrinolysis for central retinal artery occlusion: a cohort study and updated patient-level meta-analysis","volume":"51","author":"Mac","year":"2020","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102204_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/17474930231189352","article-title":"Thrombolysis for central retinal artery occlusion: an individual participant-level meta-analysis","volume":"19","author":"Shahjouei","year":"2024","journal-title":"Int J Stroke"},{"issue":"6","key":"10.1016\/j.ajoc.2024.102204_bib11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.oret.2023.01.005","article-title":"Central retinal artery occlusion: time to presentation and diagnosis","volume":"7","author":"Shah","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ajoc.2024.102204_bib12","first-page":"1","article-title":"Comparing kaiser Permanente members to the general population: implications for generalizability of research","author":"Davis","year":"2023","journal-title":"Perm J"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102204_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7812\/TPP\/15-225","article-title":"The kaiser Permanente northern California adult member Health survey","volume":"20","author":"Gordon","year":"2016","journal-title":"Perm J"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102204_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/STROKEAHA.117.018413","article-title":"Novel telestroke program improves thrombolysis for acute stroke across 21 hospitals of an integrated healthcare system","volume":"49","author":"Nguyen-Huynh","year":"2018","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102204_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/jamia.2009.001230","article-title":"International classification of diseases, 10th edition, clinical modification and procedure coding system: descriptive overview of the next generation HIPAA code sets","volume":"17","author":"Steindel","year":"2010","journal-title":"J Am Med Inform Assoc JAMIA"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102204_bib16","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1167\/iovs.05-0981","article-title":"Visual acuities \u201chand motion\u201d and \u201ccounting fingers\u201d can be quantified with the Freiburg visual acuity test","volume":"47","author":"Schulze-Bonsel","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2024.102204_bib17","article-title":"Author response: numerical imputation for low vision states","author":"Bach","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102204_bib18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s12886-023-03176-w","article-title":"Central retinal artery occlusion without cherry-red spots","volume":"23","author":"Fan","year":"2023","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2024.102204_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198114","article-title":"Intravenous thrombolysis in acute central retinal artery occlusion \u00b1 A prospective interventional case series","volume":"13","author":"Schultheiss","year":"2018","journal-title":"PLoS One"},{"issue":"9558","key":"10.1016\/j.ajoc.2024.102204_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","article-title":"SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study","volume":"369","author":"Wahlgren","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajoc.2024.102204_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.727304","article-title":"Predictors and prognosis of symptomatic intracranial hemorrhage in acute ischemic stroke patients without thrombolysis: analysis of data from the Chinese acute ischemic stroke treatment outcome registry","volume":"12","author":"Shen","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.ajoc.2024.102204_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000339675","article-title":"Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions","volume":"34","author":"Seet","year":"2012","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102204_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0161-6420(96)30631-3","article-title":"Therapeutic decisions involving disparate clinical outcomes: patient preference survey for treatment of central retinal artery occlusion","volume":"103","author":"Margo","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2024.102204_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.854288","article-title":"Inner retinal layer hyperreflectivity is an early biomarker for acute central retinal artery occlusion","volume":"9","author":"Wenzel","year":"2022","journal-title":"Front Med"},{"issue":"18","key":"10.1016\/j.ajoc.2024.102204_bib25","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMoa1917130","article-title":"BONSAI group. Artificial intelligence to detect papilledema from ocular fundus photographs","volume":"382","author":"Milea","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajoc.2024.102204_bib26","first-page":"311","article-title":"Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (An AOS Thesis)","volume":"107","author":"Kaiser","year":"2009","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajoc.2024.102204_bib27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/OPTH.S272126","article-title":"Intra-arterial tissue plasminogen activator for central retinal artery occlusion","volume":"15","author":"Sobol","year":"2021","journal-title":"Clin Ophthalmol"},{"issue":"23","key":"10.1016\/j.ajoc.2024.102204_bib28","article-title":"A remote consult retinal artery occlusion diagnostic protocol","volume":"S0161\u20136420","author":"Lema","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2024.102204_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229068","article-title":"Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: an open-label, non-randomized, first-in-humans, phase 1\/2 trial","volume":"15","author":"Ikeda","year":"2020","journal-title":"PLoS One"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624002147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624002147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T04:39:28Z","timestamp":1737693568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993624002147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":27,"alternative-id":["S2451993624002147"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102204","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A telemedicine-enabled intravenous thrombolytic treatment pathway for patients with hyperacute non-arteritic central retinal artery occlusion","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102204"}}